Evidence map›Paper›PMID 34516622›Full record

ArticleBlood advances2021

Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia.

Na Li, Nancy M Heddle, Ishac Nazy, John G Kelton, Donald M Arnold

Open access · goldAbstract read
In one paragraph

Article in Blood advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. A practical approach to immune thrombocytopenia in pregnancy.Hematology. American Society of Hematology. Education Program · 2025
    Review
  3. Article
  4. Immune attack on megakaryocytes in immune thrombocytopenia.Research and practice in thrombosis and haemostasis · 2024
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Na LiMcMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.ORCID 0000-0002-4803-0984
Nancy M HeddleMcMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.
Ishac NazyMcMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.ORCID 0000-0002-5695-4343
John G KeltonMcMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.
Donald M ArnoldMcMaster Centre for Transfusion Research, Department of Medicine, McMaster University, Hamilton, ON, Canada.ORCID 0000-0003-0943-8853
Canadian Blood Services · CAMcMaster University · CAUniversity of Calgary · CA

Funding

CIHR 165811
6 · The paper itself

Abstract

Fluctuations in platelet count levels over time may help distinguish immune thrombocytopenia (ITP) from other causes of thrombocytopenia. We derived the platelet variability index (PVI) to capture both the fluctuations in platelet count measurements and the severity of the thrombocytopenia over time. Raw PVI values, ranging from negative (less severe thrombocytopenia and/or low fluctuations) to positive (more severe thrombocytopenia and/or high fluctuations) were converted to an ordinal PVI score, from 0 to 6. We evaluated the performance characteristics of the PVI score for consecutive adults with thrombocytopenia from the McMaster ITP Registry. We defined patients with definite ITP as those who achieved a platelet count response after treatment with intravenous immune globulin or high-dose corticosteroids and possible ITP as those who never received ITP treatment or did not respond to treatment. Of 841 patients with thrombocytopenia, 104 had definite ITP, 398 had possible ITP, and 339 had non-ITP thrombocytopenia. For patients with definite ITP, the median PVI score was 5 [interquartile range (IQR) 5, 6] for patients with possible ITP, the median PVI score was 3 (1, 5); and for patients with non-ITP thrombocytopenia, the median PVI score was 0 (0, 2). A high PVI score correlated with the diagnosis of definite ITP even when calculated at the patient's initial assessment, before any treatment had been administered. Platelet count fluctuations alone contributed to the specificity of the overall PVI score. The PVI score may help clinicians diagnose ITP among patients who present with thrombocytopenia for evaluation.

Indexed as

Purpura, Thrombocytopenic, IdiopathicThrombocytopeniaAdultBlood PlateletsHumansImmunoglobulins, IntravenousPlatelet CountImmunoglobulins, Intravenous

Identifiers

PMID34516622
PMCPMC8945643
OpenAlexW3200510877

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.